Korro Bio, Inc. (KRRO) Free cash flow 2017–2025
Korro Bio, Inc. (KRRO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$79.1MFY2025 · since FY2017: -$16.5M → -$79.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$79.1M | -1.4% |
| FY2024 | -$78.0M | -3.8% |
| FY2023 | -$75.1M | -27.8% |
| FY2022 | -$58.8M | +25.6% |
| FY2021 | -$79.0M | -52.3% |
| FY2020 | -$51.9M | -256.4% |
| FY2019 | $33.2M | +289.9% |
| FY2018 | -$17.5M | -6.0% |
| FY2017 | -$16.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More KRRO financial trends
KRRO RevenueKRRO Net incomeKRRO Net marginKRRO Gross profitKRRO Gross marginKRRO Operating incomeKRRO Operating marginKRRO Operating cash flowKRRO Capital expendituresKRRO Return on equityKRRO Stock buybacksKRRO Dividends paidKRRO Total assetsKRRO Total liabilitiesKRRO Shareholders’ equityKRRO overview →